Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Castle Biosciences, Inc. is a molecular diagnostics company specializing in genomic and proteomic tests that aid clinicians in diagnosing and managing dermatologic cancers, Barrett’s esophagus, uveal melanoma, and mental health conditions. Its proprietary multi-analyte assays with algorithmic analysis provide personalized risk stratification to inform treatment decisions. The company serves primarily U.S. healthcare providers and relies on reimbursement from government and commercial payors to deliver clinically validated, evidence-based diagnostic solutions.
This description was generated via AI from an annual report. Updated about 1 year ago.